Senior Vice President, Corporate and Business Development
NanoString Technologies provides life science tools for translational research and molecular diagnostic products. The company's nCounter Analysis System has been employed in life sciences research since it was first introduced in 2008 and has been cited in more than 800 peer-reviewed publications. The nCounter Analysis System offers a cost-effective way to easily profile the expression of hundreds of genes, proteins, miRNAs, or copy number variations, simultaneously with high sensitivity and precision, facilitating a wide variety of basic research and translational medicine applications, including biomarker discovery and validation. The company's technology has also been applied to diagnostic use. The Prosigna Breast Cancer Prognostic Gene Signature Assay together with the nCounter Dx Analysis System is FDA 510(k) cleared for use as a prognostic indicator for distant recurrence of breast cancer.
Seasoned, dynamic business executive with a diverse range of transactional, venture capital, strategic planning and operational experience who thrives in dynamic, growth-oriented organizations looking to deliver significant value creation and patient benefit. Key attributes include:• Strategic insight and out-of-the-box thinking to deliver significant value and drive corporate strategy.• Comprehensive global network & relationships to uncover promising opportunities & achieve preferred status.• Results-orientation to deliver corporate goals.• First-hand experience across the biotech/pharmaceutical spectrum: Big Pharma, Mid-Cap Biotech and Venture-Backed Biotech (via Corporate Venture and Board Observer roles).
Anymail finder is trusted by tens of thousands of companies to provide accurate contact information to their Sales and Business Development teams.
If you’re looking to find the email of David W. Ghesquiere at Nanostring Technologies then you’ve come to the right place.
Wondering if it's david@nanostring.com, david.ghesquiere@nanostring.com, ghesquiere@nanostring.com, or dghesquiere@nanostring.com? We have the answers for you.